[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100630657":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":61,"collaborators":63,"id":73,"slug":20,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":74,"sex":80,"minAge":81,"maxAge":20,"enrollmentInfo":82,"targetDuration":20,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":36,"whyStopped":20,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"Diakonhjemmet Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Self-management app","EXPERIMENTAL","The patients will receive access to the self-management application 'MinUrinsyregikt' in addition to usual follow-up from their GP.",[13],"Device: Patient self-management app 'MinUrinsyregikt'",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Patient self-management app 'MinUrinsyregikt'","The purpose of the 'MinUrinsyregikt' -app is to support self-management for patients with gout receiving urate lowering therapy. The content of the app reflects current treatment recommendations for gout.\n\nThe app includes information videos and texts about gout and gout treatment, registration tools for gout flares, serum urate levels, and medication adherence. The app enables reminder alerts for medications and for blood sampling. After the monthly blood test of serum urate levels, the patients will register this value in the app and respond to two questions to validate the serum urate blood test value. The app will then provide a date for the next blood test and advice the patient to contact their GP if the serum urate level is over the treatment target.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Fiona Aanesen","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Fiona Aanesen, PhD","CONTACT","+47 22451500","fiona.aanesen@diakonsyk.no",{"name":32,"role":28,"phone":20,"phoneExt":20,"email":33},"Silje Søhus","silje.sohus@diakonsyk.no",[35],{"facility":5,"status":36,"city":37,"state":20,"zip":20,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"RECRUITING","Oslo","Norway","NO",{"type":41,"coordinates":42},"Point",[43,44],10.74609,59.91273,{"lat":44,"lon":43},[47,49,50,53,55,57,59],{"name":27,"role":28,"phone":48,"phoneExt":20,"email":30},"47 93699868",{"name":27,"role":24,"phone":20,"phoneExt":20,"email":20},{"name":51,"role":52,"phone":20,"phoneExt":20,"email":20},"Nina Østerås, PhD, Professor","SUB_INVESTIGATOR",{"name":54,"role":52,"phone":20,"phoneExt":20,"email":20},"Inger Jorid Berg, PhD, MD",{"name":56,"role":52,"phone":20,"phoneExt":20,"email":20},"Johan F H Stjärne, MD",{"name":58,"role":52,"phone":20,"phoneExt":20,"email":20},"Silje Søhus, MSc",{"name":60,"role":52,"phone":20,"phoneExt":20,"email":20},"Anne Therese Tveter, PhD, Professor",{"type":24,"investigatorFullName":23,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Postdoctoral fellow",[64,66,68,71],{"name":65,"class":6},"The Dam Foundation",{"name":67,"class":6},"The Norwegian Rheumatism Association",{"name":69,"class":70},"Diakonhjemmet Hospital AS","UNKNOWN",{"name":72,"class":70},"REMEDY - Center for treatment of Rheumatic and Musculoskeletal Diseases","100630657",false,"NCT07490522","The Remote Monitoring of Gout Feasibility Study in Primary Care","The Self-management App 'MinUrinsyregikt' for Patients With Gout. The ReMonit Gout Feasibility Study in Primary Care","ReMonit Gout","Patients are eligible to be included in the study only if all the following criteria apply:\n\n* Adults ≥18 years of age at screening\n* Patients with a clinical diagnosis of gout\n* Serum urate level \\>360 µmol\u002FL at inclusion\n* Indication for urate lowering therapy assessed by medical doctor\n* Having a smartphone\u002Ftablet\n\nPatients are excluded from the study if any of the following criteria apply:\n\n* Pregnant or breastfeeding\n* Contraindication for urate lowering therapy\n* Does not understand Norwegian language\n* Major co-morbidities (e.g., malignancies, severe chronic kidney disease, severe mental disorders)","ALL","18 Years",{"count":83,"type":84},50,"ESTIMATED","INTERVENTIONAL",[87],"NA","The goal of this feasibility study is to determine the feasibility of a patient self-management app (MinUrinsyregikt) for patients with gout. The primary objectives of the study are:\n\n1. To determine the feasibility of a patient self-management app for patients with gout receiving GP follow-up.\n2. To determine the feasibility of conducting a future randomised controlled trial to test the effectiveness of the app for patients with gout in primary care.\n\nParticipants will be asked to test the self-management app for 3 months. Data will be collected from the participants and their GPs.",[90],"Gout",[90,92,93,94,95,96],"Feasibility study","E-health","Primary care","Digital health","Urate-lowering Therapy (ULT)","2026-04-27",{"date":99,"type":100},"2026-04-30","ACTUAL",{"date":102,"type":84},"2026-04",{"date":104,"type":84},"2027-12",{"name":5,"class":6},1]